683 Capital Management »

Cortexyme shares owned by 683 Capital Management

Quarter-by-quarter ownership of Cortexyme (QNCX) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Cortexyme

Tip: Access up to 7 years of quarterly data

All positions including Cortexyme held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cortexyme by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $798k 238k 3.35

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. Put Option (LLY)
Capital One Financial (COF)
Tesla Motors Put Option (TSLA)
NVIDIA Corporation Put Option (NVDA)
Wave Life Sciences SHS (WVE)
Carvana Cl A (CVNA)
Madrigal Pharmaceuticals Put Option (MDGL)
Alnylam Pharmaceuticals (ALNY)
Praxis Precision Medicines I Com New Put Option (PRAX)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Protagonist Therapeutics (PTGX)
Gxo Logistics Incorporated Common Stock (GXO)
Hilton Grand Vacations (HGV)
Anaptysbio Inc Common (ANAB)

View all positions for 683 Capital Management

Top funds holding Cortexyme

Nantahala Capital Management
Vanguard Group
Woodline Partners
Millennium Management
Ieq Capital
Almitas Capital
Renaissance Technologies
Geode Capital Management
Jane Street
Marshall Wace
BlackRock
Susquehanna International
HighTower Advisors
683 Capital Management
State Street Corporation

View all funds holding Cortexyme